Skip to main content
Log in

India Needs Effective Surveillance to Control Hepatitis C

  • Correspondence
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fox R. Editorial. Going viral: why eliminating the burden of Hepatitis C requires enhanced cooperation between specialists and primary care providers. Dig Dis Sci. 2016;61:3381–3383. doi:10.1007/s10620-016-4301-4.

    Article  PubMed  Google Scholar 

  2. WHO India. Institute of Liver and Biliary Sciences, WHO’s new Collaborating Centre for Viral Hepatitis and Liver Diseases, 2016. www.searo.who.int/india/mediacentre/events/2015/ILBS_WHOCC/en/. Accessed December 20, 2016.

  3. Planning Commission. Twelfth Five Year Plan (2012–2017). Government of India, 2013. http://planningcommission.gov.in/plans/planrel/12thplan/pdf/12fyp_vol3.pdf. Accessed December 20, 2016.

  4. Centre, state governments spent 1.3% of GDP on healthcare in 2015–2016. Times of India. http://timesofindia.indiatimes.com/india/Centre-state-governments-spent-1-3-of-GDP-on-healthcare-in-2015-16/articleshow/53509406.cms. Accessed December 20, 2016.

  5. Lane EJ. Manufacturers in India said to hold Epclusa licenses for developing markets. www.fiercepharma.com/pharma-asia/manufacturers-india-said-to-hold-epclusa-licenses-for-developing-markets. Accessed December 20, 2016.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Govindasamy Agoramoorthy.

Ethics declarations

Conflict of interest

The author declares that he has no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agoramoorthy, G. India Needs Effective Surveillance to Control Hepatitis C. Dig Dis Sci 62, 550–551 (2017). https://doi.org/10.1007/s10620-016-4436-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-016-4436-3

Keywords

Navigation